Quest Diagnostics said on Thursday that it has received Food and Drug Administration Emergency Use Authorization for its self-collection kit for COVID-19.
Nearly all of the losses transpired in the final two weeks of March, putting its first-quarter revenue $184 million below budget, said Steven Glass, the Clinic's CFO, citing the shutdown of nonessential services to prepare for the ramping up of COVID-19 cases.
Subscription Required
In a bond filing Wednesday, Sutter Health revealed it lost $404 million in the first four months of 2020, including $168 million in April alone.
Subscription Required
The layoffs, which account for about 3% of BSW's 46,500 workers, are part of a broader workforce restructuring as COVID-19 buffets its bottom line.
Sponsored Content